Analyze These Ideas: Access a performance overview for all stocks in this article.
Written by Chris Lau, Kapitall Contributor
Stocks fall into the red by late morning Thursday as a selloff in health care soured investor sentiment.
As consumer confidence and health care spending soar, Johnson & Johnson is becoming one of the best total return packages available.
Amgen's effort to improve disappointing sales of its multiple myeloma drug Kyprolis took a hit Tuesday with the failure of a phase III clinical trial involving newly diagnosed patients.
Stocks end Monday's session sharply lower as Wall Street grows restless ahead of the first presidential debate.